Earth Science Tech, Inc. (OTC: ETST) announced fiscal first-quarter 2027 results, showcasing a 57% year-over-year increase in net income to $715,697. Revenue grew 3% to $9.0 million, while gross profit rose to $6.3 million. Operating cash flow more than doubled to $707,131, and total assets increased to $10.4 million. Diluted earnings per share improved to $0.003 from $0.001, reflecting the company's focus on shareholder value.
The company also repurchased and retired over 3.7 million common shares during the quarter without incurring additional debt, signaling confidence in its financial position. All key operating subsidiaries remained profitable, and Earth Science Tech continued to expand the licensing footprint of its compounding pharmacy operations across the United States. Management is also evaluating opportunities to broaden its telehealth and pharmacy fulfillment platforms.
These results are significant as they demonstrate the company's ability to grow profitability while maintaining a strong balance sheet. The share repurchase program, funded by operational cash flow, underscores management's commitment to enhancing shareholder returns. The continued expansion of pharmacy licensing could open new revenue streams and solidify the company's market presence.
Investors will have the opportunity to gain further insight into the company's strategic direction at the annual shareholder meeting scheduled for Aug. 31, 2026. During the meeting, shareholders will vote on proposals including the cancellation of the Series B Preferred Stock, which could simplify the capital structure. Additionally, management will provide updates on a potential exchange uplisting, a move that could improve liquidity and market visibility for the company's shares.
An uplisting to a national exchange would be a pivotal development for Earth Science Tech, potentially attracting a broader base of institutional investors and increasing trading liquidity. This could enhance the company's ability to access capital markets for future growth initiatives.
The company's diversified holding structure, encompassing compounding pharmacy, telemedicine, and direct-to-patient fulfillment, positions it well in the growing health and wellness sector. By integrating patient care from consultation to fulfillment, Earth Science Tech aims to deliver seamless services that meet evolving consumer needs.
For more information, visit the company's newsroom at https://ibn.fm/ETST.
